DK2629792T3 - Fremgangsmåde til opbevaring af en vaccine, der indeholder et aluminium-adjuvans - Google Patents

Fremgangsmåde til opbevaring af en vaccine, der indeholder et aluminium-adjuvans

Info

Publication number
DK2629792T3
DK2629792T3 DK11772945.9T DK11772945T DK2629792T3 DK 2629792 T3 DK2629792 T3 DK 2629792T3 DK 11772945 T DK11772945 T DK 11772945T DK 2629792 T3 DK2629792 T3 DK 2629792T3
Authority
DK
Denmark
Prior art keywords
adjuvance
aluminum
procedure
storing
vaccine containing
Prior art date
Application number
DK11772945.9T
Other languages
English (en)
Inventor
Nabila Ikhelef-Gribi
Frédéric Ronzon
Graf Sandrine Lentsch
Julien Tirefort
Isabelle Chacornac
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44059027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2629792(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Application granted granted Critical
Publication of DK2629792T3 publication Critical patent/DK2629792T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/005—Closures provided with linings or internal coatings so as to avoid contact of the closure with the contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
    • B65B7/2821—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers applying plugs or threadless stoppers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D39/00—Closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2539/00—Details relating to closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
    • B65D2539/001—Details of closures arranged within necks or pouring opening or in discharge apertures, e.g. stoppers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK11772945.9T 2010-10-18 2011-10-17 Fremgangsmåde til opbevaring af en vaccine, der indeholder et aluminium-adjuvans DK2629792T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1058464A FR2966044B1 (fr) 2010-10-18 2010-10-18 Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
US201161454248P 2011-03-18 2011-03-18
PCT/EP2011/068090 WO2012052394A1 (en) 2010-10-18 2011-10-17 Method of storing a vaccine containing an aluminum adjuvant

Publications (1)

Publication Number Publication Date
DK2629792T3 true DK2629792T3 (da) 2017-01-02

Family

ID=44059027

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11772945.9T DK2629792T3 (da) 2010-10-18 2011-10-17 Fremgangsmåde til opbevaring af en vaccine, der indeholder et aluminium-adjuvans

Country Status (33)

Country Link
US (2) US9066895B2 (da)
EP (1) EP2629792B1 (da)
JP (2) JP5890837B2 (da)
KR (1) KR101875828B1 (da)
CN (2) CN103140239A (da)
AP (1) AP2013006876A0 (da)
AR (2) AR084491A1 (da)
AU (1) AU2011317649B2 (da)
BR (1) BR112013009524B1 (da)
CA (1) CA2811075C (da)
CR (1) CR20130223A (da)
CY (1) CY1118557T1 (da)
DK (1) DK2629792T3 (da)
EA (1) EA026876B1 (da)
ES (1) ES2606545T3 (da)
FR (1) FR2966044B1 (da)
GE (1) GEP20156238B (da)
GT (1) GT201300094A (da)
HR (1) HRP20161637T1 (da)
HU (1) HUE031210T2 (da)
IL (1) IL225431A (da)
LT (1) LT2629792T (da)
ME (1) ME02614B (da)
MX (1) MX342345B (da)
NZ (1) NZ609973A (da)
PE (1) PE20140850A1 (da)
PL (1) PL2629792T3 (da)
PT (1) PT2629792T (da)
RS (1) RS55520B1 (da)
SI (1) SI2629792T1 (da)
UA (1) UA113049C2 (da)
WO (1) WO2012052394A1 (da)
ZA (1) ZA201303164B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
ES2948322T3 (es) 2012-06-01 2023-09-08 Novartis Ag Jeringa
KR20150023794A (ko) * 2012-06-18 2015-03-05 이노바 다이나믹스, 인코포레이티드 용기에 보관된 나노와이어 현탁액 중의 응집체 감소
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
CN103471902A (zh) * 2013-09-22 2013-12-25 北京智飞绿竹生物制药有限公司 一种解吸附方法及其应用
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
AR103244A1 (es) * 2015-02-03 2017-04-26 Merz Pharma Gmbh & Co Kgaa Recipiente precargado con toxina botulínica
KR102343004B1 (ko) 2015-12-03 2021-12-24 리제너론 파마슈티칼스 인코포레이티드 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
EP3548114A4 (en) * 2016-12-28 2020-07-15 SanBio, Inc. CELL RELEASE SYSTEM AND METHOD FOR THE OPERATION THEREOF
CN112219117A (zh) * 2018-03-20 2021-01-12 赛诺菲巴斯德有限公司 使用内源荧光测定佐剂化蛋白质浓度和吸附百分比的方法
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
DE102018124115A1 (de) * 2018-09-28 2020-04-02 Schott Schweiz Ag Primärpackmittel für pharmazeutische Substanzen
CN114555030A (zh) * 2019-10-16 2022-05-27 扬森疫苗与预防公司 疫苗产品
CN113274492B (zh) * 2021-05-21 2022-06-17 大连理工大学 一种基于羟基氧化铝纳米羧基改性的复合疫苗佐剂的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545540B2 (ja) 1987-05-29 1996-10-23 株式会社 大協精工 両面ラミネ−トゴム栓
JP3626996B2 (ja) * 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
WO1994021292A1 (en) * 1993-03-23 1994-09-29 Smithkline Beecham Biologicals (S.A.) Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
AT408615B (de) * 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
KR100385711B1 (ko) * 2000-07-05 2003-05-27 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드와 백일해균 및ｂ형간염표면항원을 포함한 4가 혼합백신 및 그 제조방법
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US7371734B2 (en) * 2002-04-22 2008-05-13 Bioniche Life Sciences Inc. Oligonucleotide compositions and their use for the modulation of immune responses
JP2004298220A (ja) * 2003-03-28 2004-10-28 Terumo Corp プレフィルドシリンジ
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
GB0610140D0 (en) * 2006-05-22 2006-06-28 Insense Ltd Protein stability
GB0522765D0 (en) 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
GB0609612D0 (en) 2006-05-15 2006-06-21 Glaxosmithkline Biolog Sa Detection method and kit
US8071544B2 (en) * 2006-12-18 2011-12-06 Althea Technologies, Inc. Crystallized recombinant human growth factor formulations
CA2716399C (en) * 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
US20110276005A1 (en) * 2008-12-03 2011-11-10 Taisei Kako Co., Ltd. Syringe

Also Published As

Publication number Publication date
BR112013009524A2 (pt) 2018-12-11
SI2629792T1 (sl) 2017-04-26
CY1118557T1 (el) 2017-07-12
EA026876B1 (ru) 2017-05-31
UA113049C2 (xx) 2016-12-12
CN103140239A (zh) 2013-06-05
MX2013003735A (es) 2013-07-29
CA2811075C (en) 2020-01-14
AR120025A2 (es) 2022-01-26
JP5890837B2 (ja) 2016-03-22
JP6577369B2 (ja) 2019-09-18
MX342345B (es) 2016-09-26
EA201390585A1 (ru) 2014-03-31
LT2629792T (lt) 2017-01-10
HUE031210T2 (en) 2017-07-28
WO2012052394A1 (en) 2012-04-26
FR2966044A1 (fr) 2012-04-20
HRP20161637T1 (hr) 2017-03-10
US9066895B2 (en) 2015-06-30
EP2629792B1 (en) 2016-11-23
JP2013541380A (ja) 2013-11-14
JP2016093534A (ja) 2016-05-26
US20120091026A1 (en) 2012-04-19
KR20130126615A (ko) 2013-11-20
FR2966044B1 (fr) 2012-11-02
CN107753944A (zh) 2018-03-06
ES2606545T3 (es) 2017-03-24
CA2811075A1 (en) 2012-04-26
NZ609973A (en) 2014-09-26
PL2629792T3 (pl) 2017-07-31
IL225431A0 (en) 2013-06-27
AU2011317649A1 (en) 2013-03-28
AU2011317649B2 (en) 2014-09-18
KR101875828B1 (ko) 2018-07-06
CR20130223A (es) 2013-06-27
PT2629792T (pt) 2016-12-16
ME02614B (me) 2017-06-20
IL225431A (en) 2017-07-31
US20150259111A1 (en) 2015-09-17
US9938055B2 (en) 2018-04-10
EP2629792A1 (en) 2013-08-28
GT201300094A (es) 2014-11-06
AP2013006876A0 (en) 2013-05-31
AR084491A1 (es) 2013-05-22
BR112013009524B1 (pt) 2021-01-26
GEP20156238B (en) 2015-01-26
PE20140850A1 (es) 2014-08-01
RS55520B1 (sr) 2017-05-31
ZA201303164B (en) 2014-06-25

Similar Documents

Publication Publication Date Title
DK2629792T3 (da) Fremgangsmåde til opbevaring af en vaccine, der indeholder et aluminium-adjuvans
DK2580156T4 (da) Fremgangsmåde til lagring af hydrogen
DK2882650T3 (da) Fremgangsmåde til håndtering af pakker
DK2457833T3 (da) Indretning til positionering af portionspakker
DK3406337T3 (da) Fremgangsmåde til fremstilling af en hydrokrakningskatalysator
DK2649101T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
DK3508081T3 (da) Inhaleringsanordning, der omfatter styring af stofanvendelse
DK3351631T3 (da) Fremgangsmåder til mærkning af dna-kodede biblioteker
DK2467204T3 (da) Fremgangsmåde til fremstilling af en sorbent
DK2813512T3 (da) Fremgangsmåde til cyklisering af en peptidforbindelse
DK2906696T3 (da) Fremgangsmåder til modulering af c9orf72-ekspression
DK2788767T3 (da) Fremgangsmåde til detektering af nukleosomaddukter
DK3312156T3 (da) Fremgangsmåder til fremstilling af (s)-1-(3-ethoxy-4-methoxyphenyl)-2-methansulfonylethylamin
DK3269802T3 (da) Forbindelser til forbedret virustransduktion
DK3661204T3 (da) Billedforudsigelse-afkodningsindretning, billedforudsigelse-afkodningsfremgangsmåde
DK3517585T3 (da) Fremgangsmåde til belægning af en fragtcontainer
DK3104003T3 (da) Nacellekonstruktion til en vindmølle
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2582416T3 (da) Holder til en injektionssprøjte
DK3985979T3 (da) Fremgangsmåde til bestemmelse af referenceenhed
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK2582283T3 (da) Fremgangsmåde til estimering af en referencestilling
DK2598479T3 (da) Fremgangsmåde til fremstilling af Ramipril
DK2884880T3 (da) Fremgangsmåde til opmåling af et dentalt emne
DK2872536T3 (da) Fremgangsmåde til ekstraktion af biomasse